Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat - PubMed
Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat
L A Dawson et al. J Neural Transm (Vienna). 2003 Jun.
Abstract
Using in vivo microdialysis in the freely moving rat we have examined the effects of 5-HT(6) receptor antagonism on the neurochemical outcome of antidepressant treatment. Acute administration of both desipramine (10 mg/kg s.c.) and venlafaxine (10 mg/kg s.c.) produced a 2 fold increase in extracellular noradrenaline (NA) but no change in frontal cortex dopamine (DaA), 5-HT or glutamate. Fluoxetine (20 mg/kg s.c.) produced no change in extracellular levels of any of the neurotransmitters examined. SB-271046 produced a 3 fold increase in extracellular glutamate. Combination treatment of SB-271046 with each antidepressant produced no change in the antidepressant-induced changes in NA, DA or 5-HT. In contrast, both fluoxetine and venlafaxine attenuated the SB-271046-induced increase in extracellular glutamate, suggesting that 5-HT and possibly NA may be having an inhibitory action on the excitatory pathways enhanced by 5-HT(6) receptor blockade. Furthermore, these data indicate that the neurochemical effects induced by NA and/or 5-HT reuptake inhibitors are not enhanced by 5-HT(6) receptor blockade indicating that 5-HT(6) receptor antagonists are unlikely to augment the therapeutic efficacy of these types of antidepressants.
Similar articles
-
Beyer CE, Boikess S, Luo B, Dawson LA. Beyer CE, et al. J Psychopharmacol. 2002 Dec;16(4):297-304. doi: 10.1177/026988110201600403. J Psychopharmacol. 2002. PMID: 12503828
-
Dawson LA, Nguyen HQ, Li P. Dawson LA, et al. Neuropsychopharmacology. 2001 Nov;25(5):662-8. doi: 10.1016/S0893-133X(01)00265-2. Neuropsychopharmacology. 2001. PMID: 11682249
-
Dawson LA, Nguyen HQ, Geiger A. Dawson LA, et al. Neuropharmacology. 1999 Aug;38(8):1153-63. doi: 10.1016/s0028-3908(99)00052-0. Neuropharmacology. 1999. PMID: 10462128
-
Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P. Blier P. J Clin Psychiatry. 2001;62 Suppl 15:12-7. J Clin Psychiatry. 2001. PMID: 11444761 Review.
-
Sánchez C, Hyttel J. Sánchez C, et al. Cell Mol Neurobiol. 1999 Aug;19(4):467-89. doi: 10.1023/a:1006986824213. Cell Mol Neurobiol. 1999. PMID: 10379421 Review.
Cited by
-
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease.
Upton N, Chuang TT, Hunter AJ, Virley DJ. Upton N, et al. Neurotherapeutics. 2008 Jul;5(3):458-69. doi: 10.1016/j.nurt.2008.05.008. Neurotherapeutics. 2008. PMID: 18625457 Free PMC article. Review.
-
Brain NMDA Receptors in Schizophrenia and Depression.
Adell A. Adell A. Biomolecules. 2020 Jun 23;10(6):947. doi: 10.3390/biom10060947. Biomolecules. 2020. PMID: 32585886 Free PMC article. Review.
-
5-HT Receptors and the Development of New Antidepressants.
Ślifirski G, Król M, Turło J. Ślifirski G, et al. Int J Mol Sci. 2021 Aug 20;22(16):9015. doi: 10.3390/ijms22169015. Int J Mol Sci. 2021. PMID: 34445721 Free PMC article. Review.
-
Lyon L, Saksida LM, Bussey TJ. Lyon L, et al. Psychopharmacology (Berl). 2012 Apr;220(4):647-72. doi: 10.1007/s00213-011-2536-5. Epub 2011 Nov 10. Psychopharmacology (Berl). 2012. PMID: 22068459 Review.
-
Andrews PW, Kornstein SG, Halberstadt LJ, Gardner CO, Neale MC. Andrews PW, et al. Front Psychol. 2011 Jul 7;2:159. doi: 10.3389/fpsyg.2011.00159. eCollection 2011. Front Psychol. 2011. PMID: 21779273 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical